Skip to main content

Table 2 Shows median fecal SCFA-concentrations (in mmol/g) in patients and controls

From: Short-chain fatty acids and intestinal inflammation in multiple sclerosis: modulation of female susceptibility by microbial products?

SCFA

Patients (n = 41)

Controls (n = 35)

p

Acetate in mmol/g median [range]

41.70 [0.07–160.26]

37.95 [0.66–193.06]

0.606

Propionate in mmol/g median [range]

5.51 [0.10–99.47]

11.38 [0.17–87.81]

0.258

Butyrate in mmol/g median [range]

1.25 [0.02–41.49]

5.49 [0.05–52.54]

0.219

IsoButyrate in mmol/g median [range]

1.31 [0.00–6.13]

2.14 [0.01–11.35]

0.171

Valerate in mmol/g median [range]

0.60 [0.00–5.64]

1.02 [0.01–19.76]

0.072

IsoValerate in mmol/g median [range]

1.00 [0.01–5.87]

2.11 [0.01–17.03]

0.128